COMMUNIQUÉS West-GlobeNewswire

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise

14/04/2025 - 14:00

– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs [...]

Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization

14/04/2025 - 14:00

Reiterates Full-Year 2025 Guidance Arsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, [...]

Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital

14/04/2025 - 14:00

The Lachine Hospital Foundation’s signature Gala raised an incredible $406,500 to support the Dream Big: Lachine Hospital campaign, a successful collaboration between the Lachine Hospital Foundation and the MUHC [...]

Le Gala de la Fondation de l'Hôpital de Lachine amasse 406 500 $ pour soutenir la modernisation de l'Hôpital de Lachine

14/04/2025 - 14:00

Le Gala signature de la Fondation de l'Hôpital de Lachine a permis de recueillir un montant impressionnant de 406 500 $ pour soutenir la campagne Oser Rêver : Hôpital de Lachine , une collaboration réussie entre la [...]

Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line

14/04/2025 - 14:00

Fort Mill, S.C., April 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac [...]

SBC Medical Group Holdings, Inc. Purchases 5 BTC

14/04/2025 - 14:00

IRVINE,Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) hereby announces that, based on the announcement of a decision to purchase Bitcoin (BTC [...]

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

14/04/2025 - 14:00

BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor [...]

Elutia Confirms No Material Impact from Global Tariffs

14/04/2025 - 14:00

SILVER SPRING, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today confirmed that the ongoing global tariff environment has [...]

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

14/04/2025 - 13:30

XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens [...]

Relmada Therapeutics To Present NDV-01 Data at AUA2025

14/04/2025 - 13:30

Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today [...]

Avicanna Reports Full Year 2024 Audited Financial Statement

14/04/2025 - 13:30

2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ [...]

SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)

14/04/2025 - 13:00

DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell [...]

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

14/04/2025 - 13:00

Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate [...]

10 Barrel Brewing Co. and Scout Campers Unveil Camp Coldie: The Ultimate Adventure Beer

14/04/2025 - 13:00

BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing , a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie , 10 Barrel Brewing Co.’s highly-crushable new 5% IPA [...]

Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025

14/04/2025 - 13:00

FRIENDSWOOD, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its [...]

Soleno Therapeutics Announces VYKAT(TM) XR Launch

14/04/2025 - 13:00

First prescriptions delivered to individuals with PWS REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics [...]

Skye Bioscience to Conduct Meetings at Piper Sandler Conference

14/04/2025 - 13:00

SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic [...]

COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer

14/04/2025 - 13:00

25+ years of experience in executive leadership roles and developing global strategic growth plans with repeatable models applicable across markets, categories and channels Current President and CEO, Gilles Gagnon to [...]

ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth

14/04/2025 - 13:00

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its [...]